MarketPulse

collaboration

8 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Unknown

Novara Energy Alliance Launches to Transform Inland Northwest Power Sector

Novara Energy Alliance launches May 7, 2026, merging Urbanova and INTENT to tackle Inland Northwest energy and water challenges through collaboration among Avista, Itron, and McKinstry.
AVAITRIrenewable energymerger
BenzingaBenzinga··Not Specified

Novara Energy Alliance Launches to Tackle Northwest's Energy and Water Challenges

Novara Energy Alliance launches from Urbanova-INTENT merger, partnering with Avista, Itron, and McKinstry to address Northwest energy and water challenges.
AVAITRImergerenergy efficiency
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Nxera Pharma Hits $10M Milestone with AbbVie on Neurology Drug Discovery

Nxera Pharma receives $10M payment from AbbVie for identifying validated drug molecules against neurological disease target using proprietary platform.
ABBVpharmaceutical developmentcollaboration
BenzingaBenzinga··Vandana Singh

Telix Pharma Surges on $2.14B Regeneron Deal for Solid Tumor Radiotherapies

Telix Pharma secures $2.14B partnership with Regeneron for solid tumor radiopharmaceuticals while reporting 11% quarterly revenue growth and FDA acceptance of brain cancer imaging application.
TLXREGNFDA approvalsolid tumors
GlobeNewswire Inc.GlobeNewswire Inc.··Not Specified

Nxera Pharma Hits Second Eli Lilly Milestone in Metabolic Disease Push

Nxera Pharma achieves second milestone with Eli Lilly validating its GPCR-targeting platform. Deal includes $694M in potential payments plus royalties.
LLYdiabetesdrug discovery
BenzingaBenzinga··Vandana Singh

Merck Bets $838M on Infinimmune's AI-Powered Antibody Platform

Merck partners with Infinimmune for next-gen antibody drugs, gaining exclusive rights to candidates from AI-powered platform with up to $838M in potential milestone payments.
MRKTERNbiotech partnershipmachine learning
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Quotient Therapeutics Lands $2.2B Merck Deal for IBD Drug Discovery Platform

Quotient Therapeutics and Merck partner on IBD drug discovery, with Quotient receiving $20M upfront and up to $2.2B in milestones.
MRKimmunologydrug discovery
BenzingaBenzinga··Prnewswire

Ericsson and Intel Team Up to Accelerate 6G Path to Market

Ericsson and Intel partner to advance 6G commercialization across networks, computing, and cloud infrastructure, with 2026 demonstrations planned.
ERICINTCedge computingnetwork infrastructure